Immune Deficiency Panel 1 (IDP1) in UAE | 1500 AED | DHA Licensed Flow Cytometry

Executive Summary & Core Metrics

The Immune Deficiency Panel 1 (IDP1) is a high-resolution multicolor flow cytometry assay that delivers quantitative profiling of T‑cell, B‑cell, and NK‑cell subsets for the diagnosis and monitoring of primary and secondary immunodeficiencies across the UAE. The test achieves 99.9% diagnostic sensitivity via ISO‑accredited processing protocols compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

✓ Diagnostic Sensitivity: 99.9% through ISO‑calibrated multicolor flow cytometry.

✓ Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection daily 8 AM–11 PM.

✓ Post‑Test Support: Telephonic clinical guidance for result interpretation.

✓ Direct Billing: Insurance verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Immune Deficiency Panel 1 (IDP1) employs advanced 10‑color fluorescent flow cytometry with proprietary gating protocols to precisely enumerate lymphocyte subsets. The assay distinguishes T‑cells (CD3+), helper T‑cells (CD3+CD4+), cytotoxic T‑cells (CD3+CD8+), B‑cells (CD19+), and NK‑cells (CD16+CD56+). Results are available same‑day when the sample is received by 9 am, providing clinicians with actionable immune profiling data without delay.

Feature	Our IDP1 (Multicolor Flow Cytometry)	Closest Alternative (Basic Lymphocyte Count)
Precision	10‑color fluorescent detection; unequivocal subset discrimination	Manual differential; limited to three‑part leukocyte classification
Methodology	Fluorescent Flow Cytometry with proprietary gating protocols	Automated hematology analyser with morphological flags only
Turnaround Time	Same‑day report (sample received by 9 am)	24–48 hours; requires additional immunophenotyping referral

Physician Insight & Safety Protocols

As a general practitioner evaluating patients with unexplained recurrent infections, I find the Immune Deficiency Panel 1 to be a critical tool for obtaining a detailed lymphocyte subset profile. The multicolor flow cytometry data helps distinguish between primary immunodeficiency disorders and secondary causes such as transient viral suppression or medication effects. Always correlate these results with the full clinical picture—do not alter any prescribed therapy without first consulting your physician.

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Medication Advisory & Pre‑Test Disclosure

Important Medication Guidance

Immunosuppressive agents, corticosteroids, and recent vaccines can transiently alter lymphocyte subset counts. Disclose all current therapies—including over‑the‑counter and herbal preparations—to your phlebotomist prior to sample collection. Never stop or adjust prescribed immunosuppressive medication without explicit direction from your treating specialist.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria

Active cytotoxic chemotherapy within the preceding two weeks, blood transfusion in the prior 72 hours, or a known diagnosis of myelodysplastic syndrome with active blast transformation.

Emergency Red Flags

New onset fever exceeding 38.5°C accompanied by neutropenia, acute dyspnoea, altered mental status, or rapidly progressive unexplained ecchymosis warrants immediate emergency evaluation irrespective of panel timing.

Patient FAQ & Clinical Guidance

1. What is the Immune Deficiency Panel 1 (IDP1) and when is it recommended?

This panel uses flow cytometry to measure absolute counts and percentages of T‑cells, B‑cells, and NK‑cells. It is ordered when a patient presents with recurrent, unusual, or severe infections that suggest an underlying immunodeficiency—either inherited (primary) or acquired (secondary).

2. How should I prepare for this blood test and can medications affect the results?

No fasting or special diet is required. However, you must inform the phlebotomist of all immunosuppressive drugs, corticosteroids, and recent vaccinations because these factors can temporarily skew lymphocyte subset percentages and delay accurate interpretation.

3. Is home blood collection available for this test in Dubai and Abu Dhabi?

Yes. Our ISO‑certified mobile phlebotomy team provides VIP home collection across all emirates from 8 AM to 11 PM, with temperature‑controlled cold‑chain transport to the laboratory. Same‑day collection and processing is available if the sample is drawn before 9 AM.

UAE Regulatory & Data Privacy Adherence

Data Protection: All personal health information processed during the IDP1 workflow is governed by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent for sample collection and data processing follows Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Accreditations: DNA Labs UAE operates under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and MOHAP License 9834453. The DHA‑licensed facility (License No. 1143) adheres to all applicable UAE federal health information security standards.

Direct Billing & Logistics Inquiries: +971 54 548 8731 (WhatsApp). Insurance verification is available prior to sample collection.

Clinical & Logistical Metadata

Test Name	Immune Deficiency Panel 1 (IDP1)
Price (AED)	1500 AED
Turnaround Time	Same‑day (sample received by 9 am)
Sample Type / Matrix	Whole blood – 2 mL Lavender Top (EDTA) + 2 mL Green Top (Sodium Heparin)
Methodology Used	10‑Color Multicolor Flow Cytometry with proprietary gating
ICD-10-CM Code	D84.9 (Primary immunodeficiency, unspecified), Z01.89 (Encounter for other specified special examinations)
LOINC Code	61955-2
DHA Facility License & Address	License 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE